Gladstone Institutional Advisory LLC Roivant Sciences Ltd. Transaction History
Gladstone Institutional Advisory LLC
- $2.1 Billion
- Q4 2024
A detailed history of Gladstone Institutional Advisory LLC transactions in Roivant Sciences Ltd. stock. As of the latest transaction made, Gladstone Institutional Advisory LLC holds 26,374 shares of ROIV stock, worth $273,762. This represents 0.01% of its overall portfolio holdings.
Number of Shares
26,374
Previous 27,684
4.73%
Holding current value
$273,762
Previous $319,000
2.19%
% of portfolio
0.01%
Previous 0.02%
Shares
2 transactions
Others Institutions Holding ROIV
# of Institutions
331Shares Held
505MCall Options Held
573KPut Options Held
739K-
Qvt Financial LP New York, NY65.8MShares$683 Million76.3% of portfolio
-
Sb Investment Advisers (Uk) LTD London, X062.1MShares$644 Million6.45% of portfolio
-
Viking Global Investors LP47.8MShares$496 Million1.91% of portfolio
-
Vanguard Group Inc Valley Forge, PA44.1MShares$458 Million0.01% of portfolio
-
Black Rock Inc. New York, NY35.4MShares$367 Million0.01% of portfolio
About Roivant Sciences Ltd.
- Ticker ROIV
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 704,382,976
- Market Cap $7.31B
- Description
- Roivant Sciences Ltd., a biopharmaceutical and healthcare technology company that researches and develops medicines. The company develops product candidates for the treatment of various therapeutics, including solid tumors, sickle cell diseases, hypophosphatasia, oncologic malignancies, psoriasis, atopic dermatitis, vitiligo, hyperhidrosis, acne...